Back to search

Article

A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virus

2018-03-05

Abstract excerpt

Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. The vaccine candidates under development require a tetravalent immunogen to induce a balanced immunity against all four serotypes of dengue virus. Herein we show that mice vaccinated with highly matured virus-like particles derived from DENV serotype 2 (mD2VLP) can generat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06cf1e46-6218-5990-92c1-815f995a27e7
DOI
10.1101/275685
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virusDOI 10.1101/275685
Select a neighboring publication to make it the new centre.